Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective clinical study in children with severe haemophilia A
2010-018644-14Phase 3Completed
- Sponsor
- Octapharma
- Start
- May 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of simoctocog alfa in hemophilia A, sponsored by Octapharma. Primary endpoints: Clinical efficacy in prevention and treatment of bleeding episodes and Pharmacokinetics of Human-cl rhFVIII. Started May 2010; status: completed.
02
Drugs
simoctocog alfa
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2010-018644-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018644-14.